{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/neutropenic-sepsis/background-information/causes/","result":{"pageContext":{"chapter":{"id":"048bb40e-2b5d-5e2d-8205-4cb6c5986b71","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field e4cece80-fea8-4038-9dff-4db84ef2b1e3 --><h2>What are the causes?</h2><!-- end field e4cece80-fea8-4038-9dff-4db84ef2b1e3 -->","summary":"","htmlStringContent":"<!-- begin item bf8480b0-050d-4ef1-ae5a-dd2e37c4b156 --><!-- begin field d060eaf1-3fb9-4521-b999-9472ac2d1a93 --><p><strong>Neutrophils are the first-line defence against infection, acting as part of the body's inflammatory response </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]<strong>. There are multiple possible causes that affect neutrophil function and/or result in a reduced neutrophil count (neutropenia) </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Kochanek, 2019</a>]<strong>.</strong></p><ul><li>Drugs and treatments<ul><li>Cytotoxic chemotherapy — febrile neutropenia is one of the most frequent and serious complications of chemotherapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Klastersky, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Morgan, 2018</a>].<ul><li>Chemotherapy causes bone marrow suppression, leading to a temporary reduction in the production of blood cells, including neutrophils, which take time to be replaced. This 'nadir' when the neutrophil count is at its lowest is typically 5–10 days after the last chemotherapy dose, and recovery is usually 5 days later, but this may vary depending on the individual drug regimen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Clarke, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Warnock, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>].</li></ul></li><li>Haematopoietic stem cell transplantation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>].</li><li>Immunosuppressive drugs such as azathioprine, methotrexate, sulfasalazine, adalimumab, and infliximab [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dmards/\">DMARDs</a> for more information.</li><li>Other drugs such as penicillin, carbimazole, phenytoin, valproic acid, clozapine, olanzapine, allopurinol, and nonsteroidal anti-inflammatory drugs (NSAIDs) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>].</li></ul></li><li>Infections<ul><li>Viral — such as HIV, influenza, hepatitis B, respiratory syncytial virus (RSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV) usually cause transient bone marrow suppression and neutropenia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>, <a class=\"topic-reference external-reference\" href=\"/topics/influenza-seasonal/\">Influenza - seasonal</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/common-cold/\">Common cold</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/\">Glandular fever (infectious mononucleosis)</a> for more information.</li><li>Bacterial — such as tuberculosis and Shigella [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/tuberculosis/\">Tuberculosis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/gastroenteritis/\">Gastroenteritis</a> for more information.</li></ul></li><li>Autoimmune<ul><li>Conditions such as Crohn's disease, rheumatoid arthritis, and systemic lupus erythematosus (SLE) increase the risk of neutropenia due to increased neutrophil destruction caused by the disease process itself [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/crohns-disease/\">Crohn&#39;s disease</a> and <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a> for more information.</li></ul></li><li>Bone marrow failure<ul><li>May be caused by conditions such as aplastic anaemia, myelodysplastic syndromes, and acute leukaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Clarke, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Warnock, 2016</a>].</li><li>Hypersplenism (Felty's syndrome).</li></ul></li><li>Nutritional deficiencies<ul><li>May be associated with vitamin B12 and folate deficiencies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>]. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a> for more information.</li></ul></li><li>Others (rare)<ul><li>Genetic conditions causing congenital neutropenia such as Kostmann's syndrome (an autosomal recessive disorder causing severe chronic neutropenia) or Cohen syndrome (characterized by developmental delay, microcephaly, and hypotonia) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>].</li></ul></li></ul><p><strong>People with neutropenia are at risk of infection from a wide range of potential pathogens.</strong></p><ul><li>Neutropenic sepsis is commonly caused by bacterial infection with Gram-positive pathogens such as <em>Staphylococcus aureus</em>, Enterococcus sp, <em>Streptococcus pneumoniae</em> and <em>S. pyogenes</em>, and less commonly Gram-negative pathogens such as <em>Escherichia coli</em>, Klebsiella sp, Enterobacter sp, and <em>Pseudomonas aeruginosa</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Lewis, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Clarke, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Ku, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Morgan, 2018</a>].</li><li>Fungal infection with Candida sp or Aspergillus sp may be involved, especially if the person has had prolonged periods of neutropenia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Rhodes, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">White, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neutropenic-sepsis/references/\">Morgan, 2018</a>].</li></ul><!-- end field d060eaf1-3fb9-4521-b999-9472ac2d1a93 --><!-- end item bf8480b0-050d-4ef1-ae5a-dd2e37c4b156 -->","topic":{"id":"c8aa50da-234b-5d4d-b2b3-1ae1d89115e0","topicId":"08d261eb-f269-42a7-801b-2cfddf69a31c","topicName":"Neutropenic sepsis","slug":"neutropenic-sepsis","lastRevised":"Last revised in March 2020","chapters":[{"id":"ade08997-70b7-5f71-ace1-e47c80bdc07a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"999bcfa1-3c00-58e5-8186-5b889008a21f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9ff15809-1783-50bc-8cc4-5fb56eb08252","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1c09fe06-1c69-51ad-8cc6-a0823851753f","slug":"changes","fullItemName":"Changes"},{"id":"1914dca9-ff88-5330-9b92-27f7df59493c","slug":"update","fullItemName":"Update"}]},{"id":"ed21973f-408a-58e8-912b-7bd2b9d0b718","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"58b41c14-2b33-5d1a-b538-099b3fca97fa","slug":"goals","fullItemName":"Goals"},{"id":"c647afae-0cce-504a-b6c3-2af1cf1df43b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9ef3011a-bd82-5da3-ad4c-e33e63dfb333","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1ff2a9b1-3f7b-5c06-8db0-0061ed24ddb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"eea45e78-ce2a-5043-85e2-4acda94fa67e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"167786d0-fb09-53a6-b02d-05105c74f541","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bafe86b3-b06d-52ce-9da2-4373bfa1b619","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4adba361-ab85-5502-b0b7-ccd33f58b0f9","slug":"definition","fullItemName":"Definition"},{"id":"048bb40e-2b5d-5e2d-8205-4cb6c5986b71","slug":"causes","fullItemName":"Causes"},{"id":"53c0b23f-7fa2-5824-b31e-6277f40216a8","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"751f6798-f767-50f9-b2b5-b23b45bc02cd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1b791a2a-8fd9-5d7c-8986-d1e27bf8e0dc","slug":"complications","fullItemName":"Complications"},{"id":"432b2287-33da-5d24-bf96-4c7e3cf898a9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2422aa1e-8340-5487-8466-e27286e03762","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"338f02ac-53b8-56c4-a0d0-df9873cabe95","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"292306b5-1418-5247-90d7-fe7ddd283226","slug":"assessment","fullItemName":"Assessment"}]},{"id":"a7a279c8-f7ee-50ec-90b2-5441d36ecceb","fullItemName":"Management","slug":"management","subChapters":[{"id":"28f8b375-c46b-5444-98d8-f753fae4bcfa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5a36b1f2-e382-5001-8945-0cef6e53ec83","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c0e91f63-5078-5363-b15a-7db7cc483396","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"740f1b28-1eb9-5160-9dd6-5a1e00f5e8c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17c51bf6-cc58-58c7-8a0a-d6caed83c5b6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c53a0347-9a44-5b20-b1b4-1adfa5b3f959","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"460cc4fe-21c5-57de-9ae3-4c27bc1ab338","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a88ff1aa-1ddd-5785-a592-ebfafff8da3e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8205950b-1254-5a4b-a51a-4a887c9da60d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"bafe86b3-b06d-52ce-9da2-4373bfa1b619","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}